All In Biotech

Free tool

FAERS Monitor: Jalyn

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022460 or its brand name (Jalyn, Dutasteride, Tamsulosin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,046

Serious

405

39% of reports

Hospitalization

191

Death reported

58

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective90
  • dizziness72
  • rash43
  • diarrhoea39
  • fatigue39
  • dyspnoea35
  • fall32
  • erectile dysfunction30
  • pruritus29
  • headache25
  • hypotension25
  • asthenia23
  • pneumonia22
  • blood pressure decreased18
  • constipation18

Reports by year received

View as table
YearReports
201012
2011200
2012187
2013109
2014105
2015111
201696
201739
201851
201939
202032
202117
202212
20235
202414
20256
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,113 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
erectile dysfunctionSignal3023.516.5625
blood pressure decreasedSignal185.43.461
dizzinessSignal722.92.390
hypotensionSignal252.51.721
rash432.01.520
fall321.91.414
constipation181.71.04
pruritus291.51.15
drug ineffective901.41.19
pneumonia221.40.92
dyspnoea351.20.91
asthenia231.20.81
diarrhoea391.20.91
fatigue391.00.70
headache250.80.51

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.